Stay updated on Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Sign up to get notified when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.

Latest updates to the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.6.3 has been added and the previous revision v3.6.2 removed, updating the page's version identifier. This is an internal software version update and does not alter the displayed study information or user-facing content.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page shows an updated Revision tag from v3.6.0 to v3.6.2. This indicates a minor internal update to the page's software/versioning and does not change the study information presented.SummaryDifference0.0%

- Check32 days agoChange DetectedThe page now states that recruitment has ended, and there are several minor UI edits including new navigation/help items and a wording change for the Intervention/Treatment label, plus an updated revision footer.SummaryDifference0.4%

- Check39 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a new build of the page was deployed. This reflects a metadata-level update rather than substantive content changes.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a new release of the study page. This change does not alter the trial data, eligibility criteria, or other substantive content.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page’s display version/revision indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.